Dr. Meletios A. Dimopoulos, MD, National and Kapodistrian University of Athens, explains Acalabrutinib is Another BTK Inhibitor Active drug for Waldenstrom Macroglobulinemia at Annual Meeting 2018
Acalabrutinib is Another BTK Inhibitor Active drug for Waldenstrom Macroglobulinemia
